{"id":77549,"date":"2013-09-10T19:09:00","date_gmt":"2013-09-10T19:09:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/"},"modified":"2013-09-10T19:09:00","modified_gmt":"2013-09-10T19:09:00","slug":"congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/","title":{"rendered":"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur"},"content":{"rendered":"

\u00a0<\/p>\n

En el marc del Congr\u00e9s de la FIP 2013, celebrat a Dubl\u00edn<\/span><\/p>\n

\u201cL\u2019\u00e8xit de la formulaci\u00f3 magistral passa per millorar la comunicaci\u00f3 amb el metge i la prescripci\u00f3 de tractaments personalitzats\u201d<\/strong><\/p>\n

Francesc Llamb\u00ed<\/strong>, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona,apunta les claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur<\/strong>\u00a0<\/p>\n

\n

\u2022 \u201cHi ha molts pacients que necessiten l\u2019adequaci\u00f3 dels tractaments i la formulaci\u00f3 magistral n\u2019\u00e9s una resposta, aquesta \u00e9s una de les raons per les quals t\u00e9 una excel\u00b7lent perspectiva en els propers anys\u201d<\/p>\n<\/blockquote>\n

Barcelona, 10 de setembre de 2013.- \u201cLa formulaci\u00f3 magistral trobar\u00e0 el seu lloc en el futur si sabem com trobar aplicacions minorit\u00e0ries per a principis actius ja registrats, establir una bona comunicaci\u00f3 amb els metges per a una millor prescripci\u00f3 de tractaments personalitzats i detectar \u00e0rees amb un volum important de poblaci\u00f3 que necessiti l\u2019adequaci\u00f3 dels tractaments a necessitats especials no cobertes per les presentacions comercialitzades\u201d. Aquestes s\u00f3n algunes de les conclusions exposades per Francesc Llamb\u00ed, president de l\u2019Associaci\u00f3 de Farmac\u00e8utics Formuladors (Aprofarm), i vocal del COF de Barcelona, el passat divendres a Dubl\u00edn en el marc del Congr\u00e9s de la FIP (International Pharmaceutical Federation).<\/p>\n

Durant la seva pon\u00e8ncia, inclosa a la sessi\u00f3 de formulaci\u00f3 magistral del Congr\u00e9s \u2013The role of compounding in closing therapeutic gaps<\/em>-, Llamb\u00ed va aportar casos i refer\u00e8ncies cient\u00edfiques recents que avalen l\u2019important paper de la formulaci\u00f3 magistral en els darrers quinze anys, amb la incorporaci\u00f3 d\u2019un important nombre de principis actius (tacrolim\u00fas \u2013immunodepressor-, tazarot\u00e8 \u2013antiacn\u00e8ic, antipsori\u00e0sic-, prednicarbat \u2013glucocorticoide-, calcipotriol \u2013antipsori\u00e0sic-, etc.), vehicles (dermocosm\u00e8tics, olis, laques, escumes, lollipops, etc.) i els seus extraordinaris resultats com a eina per a la personalitzaci\u00f3 dels tractaments.<\/p>\n

Els arguments aportats per l\u2019expert van demostrar que la formulaci\u00f3 magistral compleix totes i cada una de les\u00a0set utilitats<\/strong>\u00a0encomanades a la formulaci\u00f3 magistral actualment:<\/p>\n

\n

1. cobrir buits terap\u00e8utics;<\/p>\n

2. donar resposta terap\u00e8utica en el cas de medicacions que han deixat de comercialitzar-se per\u00f2 que continuen sent la primera opci\u00f3 de tractament, per exemple en casos com la dermatitis herpetiforme i la queratosis act\u00ednica;<\/p>\n

3. facilitar l\u2019administraci\u00f3 del medicament, ja sigui en el tractament de patologies que coexisteixen (ros\u00e0cia i dermatitis seborreica, o acne i melasma) o b\u00e9 en l\u2019optimitzaci\u00f3 de les quantitats especialment en el tractament d\u2019\u00e0rees extenses;<\/p>\n

4. ajudar en els casos d\u2019al\u00b7l\u00e8rgies i intoler\u00e0ncies;<\/p>\n

5. la individualitzaci\u00f3 dels tractaments, tant a trav\u00e9s de l\u2019ajust de les dosis com del canvi de vehicle o la combinaci\u00f3 de diferents principis actius quan \u00e9s convenient;<\/p>\n

6. la reducci\u00f3 de reaccions adverses;<\/p>\n

7. complir amb altres requeriments en pacients hospitalitzats.<\/p>\n<\/blockquote>\n

El president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona va compartir sessi\u00f3 amb experts de tot el m\u00f3n, que van posar l\u2019\u00e8mfasi en diferents aspectes de la formulaci\u00f3 magistral, des de normatives o est\u00e0ndards de qualitat, fins a les seves aplicacions en altres \u00e0rees com la pedi\u00e0trica o les precaucions de farmac\u00e8utics de tot el m\u00f3n a l\u2019hora de formular.\u00a0<\/p>\n

\u00a0\u00a0\u00a0
Per a m\u00e9s informaci\u00f3<\/strong>:\u00a0
Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona\u00a0
Tfn.: 93 244 07 28\/18 \u2013 E-mail:\u00a0premsa@cofb.net<\/a>\u00a0
Tamb\u00e9 pots consultar el nostre web:\u00a0www.cofb.org<\/a>\u00a0\/ el blog del COFB:\u00a0blog.cofb.cat<\/a>\u00a0\/ i el compte de twitter:\u00a0@farmaceuticsbcn<\/a><\/p>\n

\u00a0En el marc del Congr\u00e9s de la FIP 2013, celebrat a Dubl\u00edn\u201cL\u2019\u00e8xit de la formulaci\u00f3 magistral passa per millorar la comunicaci\u00f3 amb el metge i la prescripci\u00f3 de tractaments personalitzats\u201dFrancesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona,apunta les claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur\u00a0\u2022 \u201cHi ha molts pacients que necessiten l\u2019adequaci\u00f3 dels tractaments i la formulaci\u00f3 magistral n\u2019\u00e9s una resposta, aquesta \u00e9s una de les raons per les quals t\u00e9 una excel\u00b7lent perspectiva en els propers anys\u201dBarcelona, 10 de setembre de 2013.- \u201cLa formulaci\u00f3 magistral trobar\u00e0 el seu lloc en el futur si sabem com trobar aplicacions minorit\u00e0ries per a principis actius ja registrats, establir una bona comunicaci\u00f3 amb els metges per a una millor prescripci\u00f3 de tractaments personalitzats i detectar \u00e0rees amb un volum important de poblaci\u00f3 que necessiti l\u2019adequaci\u00f3 dels tractaments a necessitats especials no cobertes per les presentacions comercialitzades\u201d. Aquestes s\u00f3n algunes de les conclusions exposades per Francesc Llamb\u00ed, president de l\u2019Associaci\u00f3 de Farmac\u00e8utics Formuladors (Aprofarm), i vocal del COF de Barcelona, el passat divendres a Dubl\u00edn en el marc del Congr\u00e9s de la FIP (International Pharmaceutical Federation).Durant la seva pon\u00e8ncia, inclosa a la sessi\u00f3 de formulaci\u00f3 magistral del Congr\u00e9s \u2013The role of compounding in closing therapeutic gaps-, Llamb\u00ed va aportar casos i refer\u00e8ncies cient\u00edfiques recents que avalen l\u2019important paper de la formulaci\u00f3 magistral en els darrers quinze anys, amb la incorporaci\u00f3 d\u2019un important nombre de principis actius (tacrolim\u00fas \u2013immunodepressor-, tazarot\u00e8 \u2013antiacn\u00e8ic, antipsori\u00e0sic-, prednicarbat \u2013glucocorticoide-, calcipotriol \u2013antipsori\u00e0sic-, etc.), vehicles (dermocosm\u00e8tics, olis, laques, escumes, lollipops, etc.) i els seus extraordinaris resultats com a eina per a la personalitzaci\u00f3 dels tractaments.Els arguments aportats per l\u2019expert van demostrar que la formulaci\u00f3 magistral compleix totes i cada una de les\u00a0set utilitats\u00a0encomanades a la formulaci\u00f3 magistral actualment:1. cobrir buits terap\u00e8utics;2. donar resposta terap\u00e8utica en el cas de medicacions que han deixat de comercialitzar-se per\u00f2 que continuen sent la primera opci\u00f3 de tractament, per exemple en casos com la dermatitis herpetiforme i la queratosis act\u00ednica;3. facilitar l\u2019administraci\u00f3 del medicament, ja sigui en el tractament de patologies que coexisteixen (ros\u00e0cia i dermatitis seborreica, o acne i melasma) o b\u00e9 en l\u2019optimitzaci\u00f3 de les quantitats especialment en el tractament d\u2019\u00e0rees extenses;4. ajudar en els casos d\u2019al\u00b7l\u00e8rgies i intoler\u00e0ncies;5. la individualitzaci\u00f3 dels tractaments, tant a trav\u00e9s de l\u2019ajust de les dosis com del canvi de vehicle o la combinaci\u00f3 de diferents principis actius quan \u00e9s convenient;6. la reducci\u00f3 de reaccions adverses;7. complir amb altres requeriments en pacients hospitalitzats.El president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona va compartir sessi\u00f3 amb experts de tot el m\u00f3n, que van posar l\u2019\u00e8mfasi en diferents aspectes de la formulaci\u00f3 magistral, des de normatives o est\u00e0ndards de qualitat, fins a les seves aplicacions en altres \u00e0rees com la pedi\u00e0trica o les precaucions de farmac\u00e8utics de tot el m\u00f3n a l\u2019hora de formular.\u00a0\u00a0\u00a0\u00a0Per a m\u00e9s informaci\u00f3:\u00a0Departament de Comunicaci\u00f3 del Col\u00b7legi de Farmac\u00e8utics de Barcelona\u00a0Tfn.: 93 244 07 28\/18 \u2013 E-mail:\u00a0premsa@cofb.net\u00a0Tamb\u00e9 pots consultar el nostre web:\u00a0www.cofb.org\u00a0\/ el blog del COFB:\u00a0blog.cofb.cat\u00a0\/ i el compte de twitter:\u00a0@farmaceuticsbcn\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a0 En el marc del Congr\u00e9s de la FIP 2013, celebrat a Dubl\u00edn \u201cL\u2019\u00e8xit de la formulaci\u00f3 magistral passa per millorar la comunicaci\u00f3 amb el metge i la prescripci\u00f3 de tractaments personalitzats\u201d Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona,apunta les claus perqu\u00e8 la formulaci\u00f3 magistral […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77549","post","type-post","status-publish","format-standard","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"\nCongr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 En el marc del Congr\u00e9s de la FIP 2013, celebrat a Dubl\u00edn \u201cL\u2019\u00e8xit de la formulaci\u00f3 magistral passa per millorar la comunicaci\u00f3 amb el metge i la prescripci\u00f3 de tractaments personalitzats\u201d Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona,apunta les claus perqu\u00e8 la formulaci\u00f3 magistral […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-09-10T19:09:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur\",\"datePublished\":\"2013-09-10T19:09:00+00:00\",\"dateModified\":\"2013-09-10T19:09:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/\"},\"wordCount\":1159,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/\",\"name\":\"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"datePublished\":\"2013-09-10T19:09:00+00:00\",\"dateModified\":\"2013-09-10T19:09:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/","og_locale":"ca_ES","og_type":"article","og_title":"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 En el marc del Congr\u00e9s de la FIP 2013, celebrat a Dubl\u00edn \u201cL\u2019\u00e8xit de la formulaci\u00f3 magistral passa per millorar la comunicaci\u00f3 amb el metge i la prescripci\u00f3 de tractaments personalitzats\u201d Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona,apunta les claus perqu\u00e8 la formulaci\u00f3 magistral […]","og_url":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-09-10T19:09:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"6 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur","datePublished":"2013-09-10T19:09:00+00:00","dateModified":"2013-09-10T19:09:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/"},"wordCount":1159,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/","url":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/","name":"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"datePublished":"2013-09-10T19:09:00+00:00","dateModified":"2013-09-10T19:09:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/09\/10\/congres-fip-claus-perque-la-formulacio-magistral-sigui-una-eina-de-futur\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Congr\u00e9s FIP: claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 En el marc del Congr\u00e9s de la FIP 2013, celebrat a Dubl\u00edn \u201cL\u2019\u00e8xit de la formulaci\u00f3 magistral passa per millorar la comunicaci\u00f3 amb el metge i la prescripci\u00f3 de tractaments personalitzats\u201d Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona,apunta les claus perqu\u00e8 la formulaci\u00f3 magistral […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77549"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77549\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77549"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77549"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}